Latest News - Atopic Dermatitis

Monday, November 19, 2018

Case Study: Allergy Shots May Treat Severe Eczema

Allergy shots provided significant benefits to the eczema symptoms of a 48-year-old man, according to challenging case presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annua…

Read the full story

Monday, November 19, 2018

Sonoma Pharmaceuticals Launches New Ceramax Skin Barrier Lotion

Sonoma Pharmaceuticals, Inc. has launched a new Ceramax™ Skin Barrier Lotion that complements Sonoma’s current Ceramax Skin Barrier Cream. Both Ceramax products contain skin-enriching…

Read the full story

Tuesday, November 06, 2018

US FDA Grants Dupixent Priority Review for Moderate-to-Severe AD in Adolescents

The US Food and Drug Administration (FDA) has granted Priority Review for Dupixent (dupilumab) as a potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis (AD). …

Read the full story

Tuesday, October 30, 2018

New AD Estimate: As Many As 16.5 Million Adults Have AD

As many as 16.5 million adults in America have atopic dermatitis (AD). This estimate comes from a new study from the Perelman School of Medicine at the University of Pennsylvania, which also projec…

Read the full story

Friday, October 05, 2018

EPI Acquires Rights to Cloderm Cream from Promius Pharma

EPI Health has acquired the rights rights to Cloderm® (clocortolone pivalate) Cream, 0.1% and its authorized generic from Promius Pharma, LLC, a wholly owned subsidiary of D…

Read the full story

Tuesday, October 02, 2018

LEO Science & Tech Hub and Epicore Biosystems to Explore Wearable Skin Sensors to Improve Dermatologic Treatment Regimens

LEO Science & Tech Hub has established a new partnership with Epicore Biosystems focused on exploring the use of a non-invasive, wearable sweat sensor to measure prognostic biomarkers in…

Read the full story

Monday, September 17, 2018

Almirall and Evotec Form Dermatology Research Collaboration

Alrimal and Evotec aim to discover and develop first-in-class therapeutics through a novel approach to disrupt cell signaling, that is expected to deliver highly potent and durable treatments for debi…

Read the full story

Friday, September 14, 2018

Inaugural World Eczema Day: GlobalSkin Launches International Movement for Eczema Sufferers

To mark the first-ever Atopic Eczema Day, the International Alliance of Dermatology Patient Organizations (IADPO -- also known as GlobalSkin) has launched AltogetherEczema, a new movement to elevate…

Read the full story

Friday, September 14, 2018

First-Ever Molecular Study Shows African American Skin Reacts Differently to AD

African Americans are known to have greater treatment challenges with atopic dermatitis than European Americans and require higher doses of some medications to get relief, and now a new study suggests…

Read the full story

Thursday, September 06, 2018

Bee Venom May Help Treat Eczema

Bee venom and its major component, melittin, may be effective treatments for atopic dermatitis, according to a British Journal of Pharmacology study. Through studies conducted in mice and in human …

Read the full story

Tuesday, September 04, 2018

JW Pharmaceutical Signs Global Out-licensing Agreement for Atopic Dermatitis Drug Candidate with LEO Pharma

JW Pharmaceutical and LEO Pharma A/S have signed a global licensing agreement for JWP’s novel atopic dermatitis drug candidate, JW1601, under which, LEO Pharma will gain the exclusive rights to …

Read the full story

Thursday, August 23, 2018

Wake Forest Researchers: #2 in Probiotic Advancement

Scientists at Wake Forest School of Medicine say they have developed a probiotic “cocktail” derived from gut bacteria strains found in infant feces that may help increase the bod…

Read the full story

Tuesday, August 14, 2018

Burt’s Bees Nature-Based Sensitive Skin Care Outperforms MD-Recommended Regimen

Burt’s Bees nature-based sensitive skin regimen is well-tolerated as well as clinically and statistically superior to a leading dermatologist-recommended synthetic regimen, according to a s…

Read the full story

Thursday, July 26, 2018

Link Between Diet and Skin Disease Takes Center Stage at Summer AAD

Dermatologists must help patients determine if there are any foods that may cause their skin condition to flare and provide evidence-based recommendations about next steps. “People looki…

Read the full story

Friday, July 20, 2018

Trevi Therapeutics Appoints Yann Mazabraud as Chief Commercial Officer

Trevi Therapeutics, Inc. has named Yann Mazabraud as its Chief Commercial Officer and Head of International. Mr. Mazabraud will join Trevi’s senior management team and be responsible for ov…

Read the full story
Load More